You are here

  • Home
  • Archive
  • Volume 73, Issue Suppl 4
  • S130 Human mesothelioma cell lines developed from malignant pleural effusions as tools to develop novel therapies and guide personalised medicine

Article info

Article menu
Download PDFPDF
Improving outcomes for malignant pleural effusions
S130 Human mesothelioma cell lines developed from malignant pleural effusions as tools to develop novel therapies and guide personalised medicine

Authors

  • NI Kanellakis 1Laboratory of Pleural and Lung Cancer Translational Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK PubMed articlesGoogle scholar articles
  • R Asciak 1Laboratory of Pleural and Lung Cancer Translational Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK PubMed articlesGoogle scholar articles
  • X Yao 2Centre for Translational Immunology, CAMS-Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK PubMed articlesGoogle scholar articles
  • Y Peng 2Centre for Translational Immunology, CAMS-Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK PubMed articlesGoogle scholar articles
  • R Mercer 3Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK4Laboratory of Pleural and Lung Cancer Translational Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK PubMed articlesGoogle scholar articles
  • TP Sherrill 5Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, USA PubMed articlesGoogle scholar articles
  • F Maldonado 5Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, USA PubMed articlesGoogle scholar articles
  • D Ebner 6Target Discovery Institute, University of Oxford, Oxford, UK PubMed articlesGoogle scholar articles
  • LW Seymour 7Department of Oncology, University of Oxford, Oxford, UK PubMed articlesGoogle scholar articles
  • RC Rintoul 8Department of Thoracic Oncology, Papworth Hospital Foundation National Health Service Trust, Papworth Everard, Cambridge, UK PubMed articlesGoogle scholar articles
  • TS Blackwell 5Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University School of Medicine, Nashville, USA PubMed articlesGoogle scholar articles
  • GT Stathopoulos 9Comprehensive Pneumology Center and Institute for Lung Biology and Disease, University Hospital, Ludwig-Maximilian University, Munich, Germany PubMed articlesGoogle scholar articles
  • T Dong 2Centre for Translational Immunology, CAMS-Oxford Institute, Nuffield Department of Medicine, University of Oxford, Oxford, UK; MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK PubMed articlesGoogle scholar articles
  • NM Rahman 3Oxford Centre for Respiratory Medicine, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, UK PubMed articlesGoogle scholar articles
  • I Psallidas 1Laboratory of Pleural and Lung Cancer Translational Research, Nuffield Department of Medicine, University of Oxford, Oxford, UK PubMed articlesGoogle scholar articles

Citation

Kanellakis N, Asciak R, Yao X, et al
S130 Human mesothelioma cell lines developed from malignant pleural effusions as tools to develop novel therapies and guide personalised medicine
Thorax 2018;73:A81-A82.

Publication history

  • First published November 16, 2018.
Online issue publication 
September 01, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2018, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions